Literature DB >> 20186689

Functional PMS2 hybrid alleles containing a pseudogene-specific missense variant trace back to a single ancient intrachromosomal recombination event.

Christina Ganster1, Annekatrin Wernstedt, Hildegard Kehrer-Sawatzki, Ludwine Messiaen, Konrad Schmidt, Nils Rahner, Karl Heinimann, Christa Fonatsch, Johannes Zschocke, Katharina Wimmer.   

Abstract

Sequence exchange between PMS2 and its pseudogene PMS2CL, embedded in an inverted duplication on chromosome 7p22, has been reported to be an ongoing process that leads to functional PMS2 hybrid alleles containing PMS2- and PMS2CL-specific sequence variants at the 5'-and the 3'-end, respectively. The frequency of PMS2 hybrid alleles, their biological significance, and the mechanisms underlying their formation are largely unknown. Here we show that overall hybrid alleles account for one-third of 384 PMS2 alleles analyzed in individuals of different ethnic backgrounds. Depending on the population, 14-60% of hybrid alleles carry PMS2CL-specific sequences in exons 13-15, the remainder only in exon 15. We show that exons 13-15 hybrid alleles, named H1 hybrid alleles, constitute different haplotypes but trace back to a single ancient intrachromosomal recombination event with crossover. Taking advantage of an ancestral sequence variant specific for all H1 alleles we developed a simple gDNA-based polymerase chain reaction (PCR) assay that can be used to identify H1-allele carriers with high sensitivity and specificity (100 and 99%, respectively). Because H1 hybrid alleles harbor missense variant p.N775S of so far unknown functional significance, we assessed the H1-carrier frequency in 164 colorectal cancer patients. So far, we found no indication that the variant plays a major role with regard to cancer susceptibility. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186689      PMCID: PMC3341089          DOI: 10.1002/humu.21223

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Median-joining networks for inferring intraspecific phylogenies.

Authors:  H J Bandelt; P Forster; A Röhl
Journal:  Mol Biol Evol       Date:  1999-01       Impact factor: 16.240

2.  Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.

Authors:  Kaspar Truninger; Mirco Menigatti; Judith Luz; Anna Russell; Ritva Haider; Jan-Olaf Gebbers; Fridolin Bannwart; Hueseyin Yurtsever; Joerg Neuweiler; Hans-Martin Riehle; Maria Sofia Cattaruzza; Karl Heinimann; Primo Schär; Josef Jiricny; Giancarlo Marra
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

3.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

Review 4.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

5.  RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.

Authors:  J Etzler; A Peyrl; A Zatkova; H-U Schildhaus; A Ficek; S Merkelbach-Bruse; C P Kratz; A Attarbaschi; J A Hainfellner; S Yao; L Messiaen; I Slavc; K Wimmer
Journal:  Hum Mutat       Date:  2008-02       Impact factor: 4.878

6.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Authors:  Leigha Senter; Mark Clendenning; Kaisa Sotamaa; Heather Hampel; Jane Green; John D Potter; Annika Lindblom; Kristina Lagerstedt; Stephen N Thibodeau; Noralane M Lindor; Joanne Young; Ingrid Winship; James G Dowty; Darren M White; John L Hopper; Laura Baglietto; Mark A Jenkins; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-05-02       Impact factor: 22.682

7.  Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.

Authors:  Jessie Auclair; Dominique Leroux; Françoise Desseigne; Christine Lasset; Jean Christophe Saurin; Marie Odile Joly; Stéphane Pinson; Xiao Li Xu; Gilles Montmain; Eric Ruano; Claudine Navarro; Alain Puisieux; Qing Wang
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

Review 8.  Gene conversion: mechanisms, evolution and human disease.

Authors:  Jian-Min Chen; David N Cooper; Nadia Chuzhanova; Claude Férec; George P Patrinos
Journal:  Nat Rev Genet       Date:  2007-09-11       Impact factor: 53.242

9.  Discovery of human inversion polymorphisms by comparative analysis of human and chimpanzee DNA sequence assemblies.

Authors:  Lars Feuk; Jeffrey R MacDonald; Terence Tang; Andrew R Carson; Martin Li; Girish Rao; Razi Khaja; Stephen W Scherer
Journal:  PLoS Genet       Date:  2005-10-28       Impact factor: 5.917

Review 10.  Hotspots of homologous recombination in the human genome: not all homologous sequences are equal.

Authors:  James R Lupski
Journal:  Genome Biol       Date:  2004-09-28       Impact factor: 13.583

View more
  10 in total

1.  Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.

Authors:  Mark Drost; Hester Koppejan; Niels de Wind
Journal:  Hum Mutat       Date:  2013-09-11       Impact factor: 4.878

Review 2.  Long non-coding RNAs in cancer: implications for personalized therapy.

Authors:  Marianna Vitiello; Andrea Tuccoli; Laura Poliseno
Journal:  Cell Oncol (Dordr)       Date:  2014-08-12       Impact factor: 6.730

3.  PMS2 inactivation by a complex rearrangement involving an HERV retroelement and the inverted 100-kb duplicon on 7p22.1.

Authors:  Julia Vogt; Annekatrin Wernstedt; Tim Ripperger; Brigitte Pabst; Johannes Zschocke; Christian Kratz; Katharina Wimmer
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

4.  Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria.

Authors:  Maribel González-Acosta; Jesús Del Valle; Matilde Navarro; Bryony A Thompson; Sílvia Iglesias; Xavier Sanjuan; María José Paúles; Natàlia Padilla; Anna Fernández; Raquel Cuesta; Àlex Teulé; Guido Plotz; Juan Cadiñanos; Xavier de la Cruz; Francesc Balaguer; Conxi Lázaro; Marta Pineda; Gabriel Capellá
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

5.  Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome.

Authors:  Annette F Baas; Michael Gabbett; Milan Rimac; Minttu Kansikas; Martine Raphael; Rutger Aj Nievelstein; Wayne Nicholls; Johan Offerhaus; Danielle Bodmer; Annekatrin Wernstedt; Birgit Krabichler; Ulrich Strasser; Minna Nyström; Johannes Zschocke; Stephen P Robertson; Mieke M van Haelst; Katharina Wimmer
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

6.  panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.

Authors:  Gundula Povysil; Antigoni Tzika; Julia Vogt; Verena Haunschmid; Ludwine Messiaen; Johannes Zschocke; Günter Klambauer; Sepp Hochreiter; Katharina Wimmer
Journal:  Hum Mutat       Date:  2017-05-16       Impact factor: 4.878

7.  Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.

Authors:  Annekatrin Wernstedt; Emanuele Valtorta; Franco Armelao; Roberto Togni; Salvatore Girlando; Michael Baudis; Karl Heinimann; Ludwine Messiaen; Noemie Staehli; Johannes Zschocke; Giancarlo Marra; Katharina Wimmer
Journal:  Genes Chromosomes Cancer       Date:  2012-05-14       Impact factor: 5.006

8.  Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.

Authors:  Sun Hee Rosenthal; Weimin Sun; Ke Zhang; Yan Liu; Quoclinh Nguyen; Anna Gerasimova; Camille Nery; Linda Cheng; Carolyn Castonguay; Elaine Hiller; James Li; Christopher Elzinga; David Wolfson; Alla Smolgovsky; Rebecca Chen; Arlene Buller-Burckle; Joseph Catanese; Andrew Grupe; Felicitas Lacbawan; Renius Owen
Journal:  Biomed Res Int       Date:  2020-01-22       Impact factor: 3.411

Review 9.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 10.  The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?

Authors:  Maciej Stasiak; Tomasz Kolenda; Joanna Kozłowska-Masłoń; Joanna Sobocińska; Paulina Poter; Kacper Guglas; Anna Paszkowska; Renata Bliźniak; Anna Teresiak; Urszula Kazimierczak; Katarzyna Lamperska
Journal:  Life (Basel)       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.